Table 2 Patient- and disease characteristics according to breast cancer death among Swedish women diagnosed with breast cancer at age 40+ from July 1st, 2005 to December 31st, 2008. They were followed up until December 31st, 2012 for breast cancer related death, and, December 31st, 2013 for all-cause mortality
From: Statin use and breast cancer survival – a Swedish nationwide study
Characteristics | All | Not dead in breast cancer | Breast cancer related death | |
|---|---|---|---|---|
Age at breast cancer diagnosis | N | 20,559 | 17,890 | 2669 |
Median (min, max | 63 (40,102) | 62 (40,101) | 75 (40,102) | |
Mean (SD) | 64 (13) | 63 (12) | 72 (14) | |
Regular statin user | ||||
No | 7717 (87.6%) | 6887 (87.5%) | 830 (88.2%) | |
Yes | 1092 (12.4%) | 981 (12.5%) | 111 (11.8%) | |
Diabetes mellitus pre-breast cancer diagnosis | ||||
No | 19,343 (94.1%) | 16,957 (94.8%) | 2386 (89.4%) | |
Yes | 1216 (5.9%) | 933 (5.2%) | 283 (10.6%) | |
All cause mortality | ||||
No | 15,881 (77.2%) | 15,881 (88.8%) | 0 (0%) | |
Yes | 4678 (22.8%) | 2009 (11.2%) | 2669 (100%) | |
Breast cancer stage at diagnosis | ||||
Missing | 7383 (35.9%) | 6247 (34.9%) | 1136 (42.6%) | |
0 | 3506 (17.1%) | 3394 (19%) | 112 (4.2%) | |
1 | 4818 (23.4%) | 4640 (25.9%) | 178 (6.7%) | |
2 | 3419 (16.6%) | 2882 (16.1%) | 537 (20.1%) | |
3 | 855 (4.2%) | 556 (3.1%) | 299 (11.2%) | |
4 | 578 (2.8%) | 171 (1%) | 407 (15.2%) | |
Type of statin before breast cancer diagnosis | ||||
No | 17,817 (86.7%) | 15,507 (86.7%) | 2310 (86.5%) | |
Lipophilic | 2549 (12.4%) | 2210 (12.4%) | 339 (12.7%) | |
Hydrophilic | 193 (0.9%) | 173 (1%) | 20 (0.7%) | |